HomeStoryRoche Taps AI to Find Cancer Patients After Trial Success

Roche Taps AI to Find Cancer Patients After Trial Success

Published on

spot_img
Precision Cancer Consortium Taps Massive Bio's AI Analytics for Clinical  Trial Matching | Inside Precision Medicine
  1. Roche, a prominent pharmaceutical company, is using Artificial Intelligence (AI) technology in its efforts to identify cancer patients.
  2. The decision to use AI for patient identification follows the success of a clinical trial, although specific details about the trial and its results are not provided in the given information.
  3. AI has been increasingly integrated into healthcare to enhance various aspects, including early disease detection, treatment recommendations, and drug development.
  4. The use of AI in cancer patient identification can potentially lead to earlier diagnosis and more tailored treatment plans, ultimately improving patient outcomes.
  5. Roche’s adoption of AI technology reflects the broader trend of pharmaceutical and healthcare companies incorporating AI into their processes and research to advance medical science and patient care.

Latest articles

Adani Group plans $84 billion in the next 10 years : CFO

Adani Group plans to invest Rs 7 trillion ($84 billion) in infrastructure over the...

Indian banks set 10-year record with 123,000 hirings in FY23

Indian banks experienced a notable surge in hiring during FY23, reaching a decade-high in...

Ahead of IPO, Mamaearth sold excess stock of its products to distributors

Honasa Consumer, the parent company of Mamaearth, distributed excess stock through its offline supply...

CarDekho acquires Revv to enter car rental space

CarDekho, an autotech unicorn, acquired Revv, a self-drive car rental service. Revv's services will be...

More like this

Adani Group plans $84 billion in the next 10 years : CFO

Adani Group plans to invest Rs 7 trillion ($84 billion) in infrastructure over the...

Indian banks set 10-year record with 123,000 hirings in FY23

Indian banks experienced a notable surge in hiring during FY23, reaching a decade-high in...

Ahead of IPO, Mamaearth sold excess stock of its products to distributors

Honasa Consumer, the parent company of Mamaearth, distributed excess stock through its offline supply...